The cell biology of major histocompatibility complex class I assembly: towards a molecular understanding A Van Hateren, E James, A Bailey, A Phillips, N Dalchau, T Elliott Tissue antigens 76 (4), 259-275, 2010 | 70 | 2010 |
Selector function of MHC I molecules is determined by protein plasticity A Bailey, N Dalchau, R Carter, S Emmott, A Phillips, JM Werner, T Elliott Scientific reports 5 (1), 14928, 2015 | 69 | 2015 |
A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteins A van Hateren, R Carter, A Bailey, N Kontouli, AP Williams, J Kaufman, ... Journal of Biological Chemistry 288 (45), 32797-32808, 2013 | 55 | 2013 |
Dynamically driven allostery in MHC proteins: Peptide-dependent tuning of class I MHC global flexibility CM Ayres, ET Abualrous, A Bailey, C Abraham, LM Hellman, SA Corcelli, ... Frontiers in immunology 10, 966, 2019 | 42 | 2019 |
Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control A van Hateren, A Bailey, T Elliott F1000Research 6, 2017 | 41 | 2017 |
Direct evidence for conformational dynamics in major histocompatibility complex class I molecules A van Hateren, M Anderson, A Bailey, JM Werner, P Skipp, T Elliott Journal of Biological Chemistry 292 (49), 20255-20269, 2017 | 30 | 2017 |
Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function A van Hateren, A Bailey, JM Werner, T Elliott Molecular Immunology 68 (2), 98-101, 2015 | 26 | 2015 |
Two polymorphisms facilitate differences in plasticity between two chicken major histocompatibility complex class I proteins A Bailey, A van Hateren, T Elliott, JM Werner PLoS One 9 (2), e89657, 2014 | 22 | 2014 |
Removal of abnormal prion protein by plasma fractionation PR Foster, C McLean, AG Welch, BD Griffin, JC Hardy, A Bartley, ... Transfusion Science 22 (1), 53-56, 2000 | 18 | 2000 |
Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands B Nicholas, A Bailey, KJ Staples, T Wilkinson, T Elliott, P Skipp PLoS Pathogens 18 (1), e1009894, 2022 | 10 | 2022 |
Characterization of the class i MHC peptidome resulting from DNCB exposure of HaCaT cells A Bailey, B Nicholas, R Darley, E Parkinson, Y Teo, M Aleksic, G Maxwell, ... Toxicological Sciences 180 (1), 136-147, 2021 | 7 | 2021 |
Identification of neoantigens in oesophageal adenocarcinoma B Nicholas, A Bailey, KJ McCann, O Wood, RC Walker, R Parker, ... Immunology 168 (3), 420-431, 2023 | 6 | 2023 |
Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells E Parkinson, M Aleksic, P Kukic, A Bailey, R Cubberley, P Skipp Toxicology 445, 152603, 2020 | 6 | 2020 |
Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting A Aguzzi, J Barbara, P Brown, H Budka, H Diringer, D Dormont, ... Bulletin of the World Health Organization 75 (6), 505-513, 1997 | 6 | 1997 |
The immunopeptidomes of two transmissible cancers and their host have a common, dominant peptide motif A Gastaldello, SH Ramarathinam, A Bailey, R Owen, S Turner, N Kontouli, ... Immunology 163 (2), 169-184, 2021 | 3 | 2021 |
Transmissible Spongiform Encephalopathies. Managing risk in mammalian organs, cells and sera. 15-16 March 1999, San Diego, CA, USA. AC Bailey IDrugs: the investigational drugs journal 2 (6), 564-566, 1999 | 3 | 1999 |
Analysis of cell‐specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction B Nicholas, J Guo, HH Lee, A Bailey, R de Waal Malefyt, M Cicmil, ... Clinical and Experimental Allergy 52 (11), 1334, 2022 | 2 | 2022 |
The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers RS Owen, SH Ramarathinam, A Bailey, A Gastaldello, K Hussey, ... PLoS Pathogens 17 (11), e1010033, 2021 | 2 | 2021 |
Passage of transmissible cancers in the Tasmanian devil is due to a dominant, shared peptide motif and a limited repertoire of MHC-I allotypes A Gastaldello, SH Ramarathinam, A Bailey, R Owen, S Turner, A Kontouli, ... bioRxiv, 2020.07. 03.184416, 2020 | 2 | 2020 |
Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use J Hällqvist, D Lane, A Shapanis, K Davis, WE Heywood, I Doykov, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (2), 302-310, 2023 | 1 | 2023 |